Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies.
J. Pathol.; 226: 132–142. 2012 Jan; doi: 10.1002/path.2984.
Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models.
The Journal of Biological Chemistry; 2011 Sept 30 The Journal of Biological Chemistry, 286, 34457-34467.2011 Aug 12, doi: 10.1074/jbc.M111.229633.
Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease.
J Biol Chem; 2011 Jul 1;286(26):23063-76. Epub 2011 May 6; PMID: 21550980; PMCID: PMC3123074.
Compounds and Compositions for Use as Modulators of Tau Aggregation and Alleviation of Tauopathies
. United States Patent Application; United States Patent Application 20110144124; 2011 June 16; DOI: y2011/0144124.html.
Tau Transgenic Mice as Models for Cerebrospinal Fluid Tau Biomarkers.
Journal of Alzheimer’s Disease; Volume 24, Supplement 2/ 2011 Mar 18 DOI: 10.3233/JAD-2011-110161.
Regulation of protein phosphatase 2A methylation by LCMT1 and PME-1 plays a critical role in differentiation of neuroblastoma cells.
J Neurochem; 2010 Dec;115(6):1455-65. doi: 10.1111/j.1471-4159.2010.07049.x.
Expression and silencing of the microtubule-associated protein Tau in breast cancer cells.
Mol Cancer Ther; 2010 Nov; 9 (11) :2970-81. PubMed PMID:21062914.
Loss of Hsp110 leads to age-dependent tau hyperphosphorylation and early accumulation of insoluble amyloid beta.
Mol Cell Biol.; 2010 Oct; 30 (19) :4626-43. PubMed PMID:20679486; PubMed Central PMCID: PMC2950521.
Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy.
Neuron; 2010 Sep 23;67(6):953-66. Doi 10.1016/j.neuron.2010.08.044.
New evidences on Tau-DNA interactions and relevance to neurodegeneration.
Neurochem Int; 2010 Aug; 57 (1) :51-7. PubMed PMID:20435075.